Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.53−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $224.80MP/E –Yield –
Canopy Growth operating margin
Operating margin is operating income as a percentage of revenue.
Canopy Growth's operating margin for the twelve months ending Jun 30, 2026 was -54.9%. For fiscal 2026 it was -56.8%, against -43.5% the year before. The highest annual figure on record is -35.3% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -56.8% | −13.3 |
| FY2025 | Mar 31, 2025 | -43.5% | +33.4 |
| FY2024 | Mar 31, 2024 | -77.0% | +712.4 |
| FY2023 | Mar 31, 2023 | -789.3% | −575.2 |
| FY2022 | Mar 31, 2022 | -214.2% | +13.3 |
| FY2021 | Mar 31, 2021 | -227.5% | +191.1 |
| FY2020 | Mar 31, 2020 | -418.5% | −136.9 |
| FY2019 | Mar 31, 2019 | -281.6% | −128.2 |
| FY2018 | Mar 31, 2018 | -153.4% | −118.1 |
| FY2017 | Mar 31, 2017 | -35.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -27.2% | +4.1 |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -134.5% | −106.4 |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -35.3% | −3.5 |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -25.3% | +47.6 |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -31.4% | +12.6 |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -28.1% | +118.5 |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -31.9% | +45.0 |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -72.9% | −62.9 |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -44.0% | +27.7 |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -146.6% | +651.7 |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -76.8% | +56.0 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -10.1% | +159.6 |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -71.7% | +1667.8 |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -798.4% | −104.7 |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -132.8% | −26.4 |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -169.6% | −5.7 |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -1739.4% | −1601.6 |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -693.7% | −536.6 |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -106.4% | +256.6 |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -163.9% | +46.2 |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -137.8% | +18.3 |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -157.1% | +761.3 |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -363.0% | −207.5 |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -210.2% | +143.4 |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -156.1% | +81.2 |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -918.4% | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -155.4% | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -353.5% | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -237.3% | – |
See a number that looks wrong?